This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
The product basket increased to 1800 medicines and 285 Surgical Equipment
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
Subscribe To Our Newsletter & Stay Updated
